Skip to main content
Substance Abuse Treatment, Prevention, and Policy logoLink to Substance Abuse Treatment, Prevention, and Policy
. 2026 Feb 2;21:8. doi: 10.1186/s13011-026-00710-z

Effects of a Relapse Prevention Program on motivation, relapse, and stress management in correctional settings

Abdón Martín-Coca 1,✉, José Antonio Martín Herrero 1
PMCID: PMC12874843  PMID: 41629921

Abstract

Background

Incarcerated individuals with substance use disorders face a high risk of relapse in the absence of structured, motivational, and context-adapted interventions. This study examined changes associated with the implementation of a Relapse Prevention Program designed to enhance motivation for change, anticipate early warning signs of relapse, and strengthen adaptive coping strategies. The intervention integrated Marlatt and Gordon’s Relapse Prevention Model with the COM-B framework (Capability, Opportunity, and Motivation) and Michie’s Behaviour Change Wheel, constituting an original proposal in prison settings.

Results

A pre–post quasi-experimental design was conducted with participants from three prison units. Outcome measures included the SOCRATES 8D scale (motivation), the AWARE scale (perceived relapse risk), and the Brief COPE inventory (coping strategies). The findings indicated preliminary improvements in motivation for change, particularly in problem recognition and action steps. Improvements were also observed in adaptive coping strategies, including active coping, positive reframing, and planning. No significant changes were detected in perceived relapse risk. Female participants showed greater improvements in coping strategies and lower post-intervention substance use.

Conclusions

These findings support the feasibility and clinical applicability of the program in prison settings. The results underscore the importance of integrating emotional regulation components and a gender-responsive perspective into relapse prevention programmes for incarcerated individuals with substance use disorders.

Supplementary Information

The online version contains supplementary material available at 10.1186/s13011-026-00710-z.

Keywords: Substance-related disorders, Relapse prevention, Prisons, Motivation, Psychological adaptation, Psychological intervention, Gender-responsive intervention

Introduction

Reducing the risk of relapse is a central goal in the treatment of substance use disorders, particularly in prison settings, where relapse remains frequent and complex [43, 63]. Incarcerated individuals show higher rates of substance use disorders and psychiatric comorbidity than the general population, which increases relapse risk and complicates both rehabilitation and social reintegration processes [6, 21, 65]. Although structured psychological interventions with empirical support have been implemented in prison contexts, available evidence remains heterogeneous, and there is a persistent need for higher-quality evaluations, especially regarding outcomes following release into the community [7, 16].

From a cognitive–behavioural perspective, relapse prevention is conceptualised as a dynamic process shaped by individual, environmental, and behavioural factors. The classic model proposed by Marlatt and Gordon [42] describes relapse as a sequence of interrelated events, in which early identification of high-risk situations and the deployment of adaptive coping strategies are critical. Variables such as self-efficacy, emotional regulation, and substance-related expectancies have been consistently identified as key predictors of relapse risk [5, 66]. In this regard, Melemis [45] emphasises the central role of emotional regulation and stress management in promoting adaptive responses under conditions of high vulnerability.

From a neuroscientific perspective, substance use disorders have been associated with alterations in prefrontal cortical functioning and reward-related neural circuits, which negatively affect impulse control and decision-making, particularly in stressful environments such as prisons [29, 36]. Prolonged exposure to adverse prison conditions may exacerbate these dysfunctions and increase relapse risk by further impairing emotional regulation capacities [25, 60].

Within this context, the COM-B model and the Behaviour Change Wheel (BCW) provide a robust theoretical framework for the design of public health and behaviour change interventions, particularly relevant for populations facing multiple personal and contextual barriers. This framework posits that behaviour emerges from the interaction of three core components: capability (psychological and physical), opportunity (social and environmental), and motivation (automatic and reflective) [46, 47]. In the present study, this structure informed the design of an integrated intervention that simultaneously addressed individual, interpersonal, and structural factors involved in relapse among incarcerated individuals. Specifically, capability was targeted through training in adaptive coping strategies, motivation was enhanced using motivational interviewing techniques, and opportunity was examined in relation to institutional environmental conditions. This conceptual logic was also reflected in the selection of assessment instruments: the SOCRATES scale (motivation for change), the AWARE scale (anticipation of relapse), and the Brief COPE inventory (coping strategies).

The specialised literature has consistently identified three core components in relapse prevention: motivation for change, early detection of warning signs, and the development of effective coping strategies [40, 42, 46, 66]. Motivation is a critical determinant due to its influence on treatment adherence, whereas the ability to identify precipitating factors and respond appropriately to high-risk situations constitutes a key resource for reducing relapse probability [25].

A growing body of empirical evidence, including systematic reviews and meta-analyses, supports the effectiveness of structured psychological interventions delivered in prison settings in reducing adverse post-release outcomes, including criminal recidivism. In particular, cognitive–behavioural programmes have been associated with reductions in recidivism in randomised controlled trials, although findings vary across studies and highlight the need for further high-quality research [7]. In the specific domain of substance use treatment, a systematic review focusing on in-prison interventions concluded that certain programmes can improve recidivism outcomes and, in some cases, post-release substance use, although effect sizes differ depending on intervention modality and intensity [16].

Complementarily, recent public health syntheses indicate that effective interventions exist to reduce harms and adverse outcomes associated with substance use among individuals with prison experience, underscoring the importance of integrated and sustained strategies [39]. From a public health perspective, the integration of substance use treatment within the criminal justice system has been consistently advocated as a means to improve health and safety outcomes, particularly when continuity of care during the transition to the community is ensured [12]. Moreover, in populations with psychiatric comorbidity, evidence from systematic reviews suggests that interventions must be tailored to concurrent needs and that effectiveness may depend on treatment fit and implementation context [31, 51]. Finally, qualitative syntheses and implementation studies highlight that programme delivery in prison settings is shaped by organisational and environmental barriers, and that institutional support and treatment fidelity are critical to sustaining the effects observed in research settings [27, 35].

Despite this body of evidence, published research explicitly evaluating the combination of the classic relapse prevention approach with contemporary behaviour change frameworks in prison settings remains limited. The present study addresses this gap in a population characterised by polysubstance use, early onset of substance use (before the age of 18), and previous exposure to both outpatient and residential treatment modalities. This profile, common in specialised prison units and associated with high clinical complexity, provides a relevant context in which to examine the performance of a structured intervention.

Relapse prevention occupies a central position within cognitive–behavioural approaches to substance use disorders, and accumulated quantitative evidence supports the overall efficacy of cognitive–behavioural therapy in improving substance use outcomes compared with minimal or non-specific conditions [40]. The COM-B model and the Behaviour Change Wheel, in turn, offer a systematic method for designing interventions based on the analysis of capability, opportunity, and motivation as behavioural determinants [46]. Although the BCW has been used to characterise determinants and guide strategies in prison contexts, the explicit integration of these frameworks into an applied programme in this setting has received limited empirical evaluation, further justifying the present study [27].

The aim of this study is to analyse the effectiveness of a programme grounded in Marlatt and Gordon’s relapse prevention model and the COM-B/BCW theoretical framework in a prison population. Specifically, the study evaluates its impact on: (1) motivation for change, (2) identification of early warning signs of relapse, and (3) the use of adaptive coping strategies for managing stress. In addition, potential differences across specific participant profiles are explored in order to inform the development of future interventions tailored to the characteristics of this population.

Method

Procedure and intervention

The Relapse Prevention Program (RPP) was implemented over a 12-week period, between April and June 2024, at the Topas Prison (Salamanca, Spain). The intervention consisted of weekly 80-minute group sessions focused on motivation for change, early identification of relapse warning signs, training in coping strategies and emotional regulation, stress management, and cognitive restructuring. The weekly content plan is detailed in Table 1 and included specific modules on emotional regulation, anticipation of high-risk situations, and resilience strengthening.

Table 1.

Relapse prevention programme contents

Week Topic Activities
1–2 Initial Assessment and Motivation for Change Administration of instruments (SOCRATES 8D, AWARE, Brief COPE) and establishment of individual goals. Introduction to the program and initial design of the therapeutic plan, integrating the COM-B model as a conceptual framework.
3 Identification of Warning Signs and Risk Factors Analysis of personal relapse history. Work on precipitating factors and early warning signs. Application of the COM-B model to explore contextual and motivational barriers.
4–5 Coping Strategies and Emotional Regulation Development of stress and anxiety management skills using cognitive-behavioral techniques, with emphasis on self-efficacy.
6–7 Cognitive Restructuring and Planning for Risk Situations Identification of dysfunctional thoughts. Design of adaptive responses to high-risk scenarios. Planning of actions based on individual capabilities and opportunities.
8–9 Consolidation and Simulation of Maintenance Strategies Group simulation of risk situations. Reinforcement of adaptive strategies and self-evaluation. Exploration of intrinsic motivation.
10 Long-Term Relapse Prevention Development of a personalized maintenance plan incorporating elements of follow-up, self-efficacy, and coping with foreseeable barriers.
11–12 Final Evaluation and Follow-Up Planning Re-administration of initial questionnaires to assess change. Review of individual progress. Design of a post-release continuity plan adapted to the post-prison context.

The initial sample comprised 32 incarcerated individuals, selected by the prison Treatment Team based on clinical criteria and voluntary participation. A total of 28 participants completed the programme, following four dropouts due to transfer or personal decision. Participants were distributed across three units: (1) the Mental Health Unit, with nine men aged 19–42 years; (2) the Therapeutic and Educational Unit (UTE), with nine men aged 26–58 years; and (3) the Women’s Unit, with ten women aged 31–52 years. All participants had initiated substance use before the age of 18 and had prior experience with outpatient and/or residential treatment.

Participants belonged to pre-existing clinical groups within the institution that had been established for therapeutic intervention. Selection was carried out by the prison clinical team based on availability, clinical profile, and provision of written informed consent. This condition enhanced the ecological validity of the study, although it limited randomisation and control over potential external variables.

During programme implementation, differences existed across units with regard to treatment as usual, which was not part of the RPP design and was not modified for the purposes of the study. In the UTE, treatment as usual included support groups, therapeutic groups, and individual therapeutic follow-up within an organised therapeutic community offering voluntary rehabilitative activities. In the Mental Health Unit, participants engaged in institutionally organised group therapies. In the Women’s Unit, routine intervention focused primarily on occupational activities. These concurrent interventions were not systematically quantified; therefore, their contribution to pre–post changes cannot be estimated and should be considered a potential confounding factor in the interpretation of results.

The RPP was delivered using the same structure, methodology, core contents, and session sequence across all three units, in accordance with the programme manual and session outline (Table 1). All sessions were conducted by the same psychologist (first author), which contributed to intervention consistency across groups. Adaptations were limited to operational adjustments required to fit the organisational dynamics of each unit and did not affect the core components of the programme.

The study was approved by the Ethics Committee of the University of Salamanca (CEISH), registration number 1155, by resolution dated 7 March 2024. The intervention was authorised by the Ministry of the Interior and the General Secretariat of Penitentiary Institutions on 21 March 2024. All procedures were conducted in accordance with the Declaration of Helsinki, and all participants provided written informed consent prior to participation.

Measures

Motivation for change was assessed using the Stages of Change Readiness and Treatment Eagerness Scale (SOCRATES-8D; [50]), which evaluates problem recognition, ambivalence, and taking steps. Its factor structure and evidence of construct validity have been examined in samples with substance use disorders, and several studies suggest predictive value—particularly for the taking steps dimension—regarding subsequent substance use outcomes (e.g., [9, 17]).

Relapse risk perception was assessed using the Advance WArning of RElapse (AWARE; 25 items), developed to operationalise early warning signs of relapse [48]. Subsequent work has supported an essentially unidimensional structure and provided evidence of convergent and predictive validity; in particular, a refined 25-item factor was identified in a sample of young adults, showing the ability to predict relapse and to provide incremental utility beyond clinically relevant covariates [33].

Coping strategies for managing stress were assessed using the Spanish version of the Brief COPE Inventory [11, 22]. This questionnaire consists of 28 items grouped into 14 subscales: active coping, planning, use of instrumental support, use of emotional support, self-distraction, emotional ventilation, behavioural disengagement, positive reframing, denial, acceptance, religion, substance use, humour, and self-blame. The scale shows good psychometric properties, adequate factorial fit, and validation across diverse contexts, and is particularly useful for distinguishing adaptive strategies (e.g., active coping) from maladaptive strategies (e.g., denial, substance use) in prison populations exposed to high levels of stress [22, 32, 52].

Finally, an ad hoc Global Questionnaire was administered to assess participants’ perceptions of the programme, covering dimensions such as understanding of addiction, identification of relapse warning signs, risk management, and confidence in maintaining abstinence (see Supplementary Material, Sect. 1). This instrument showed excellent internal consistency (α = 0.93) and was developed following contemporary guidelines for scale development in health research [8], grounded in Bandura’s [5] self-efficacy model.

Internal consistency (Cronbach’s alpha) was estimated for all measures in the present sample. The AWARE scale showed excellent internal consistency at both assessment points (α = 0.94; α = 0.95). The ad hoc questionnaire also demonstrated excellent consistency (α = 0.93). The Brief COPE, considered at the global level (28 items), showed adequate internal consistency (α = 0.80; α = 0.84). By contrast, internal consistency for the SOCRATES-8D was below commonly recommended thresholds (α = 0.30; α = 0.55), which represents a limitation and warrants cautious interpretation of results based on this measure in the present sample. Given that Cronbach’s alpha alone does not constitute evidence of validity, and considering the substantial prior evidence supporting the construct validity of the instrument, it was retained in the analyses with this limitation explicitly acknowledged [50, 58]. Detailed values are provided in the Supplementary Material (Sect. 2).

All instruments were administered at two time points (pre-intervention, M1; post-intervention, M2), except for the Global Questionnaire, which was administered only at M2, as detailed in Table 1.

Data analysis plan

Pre–post comparisons on scale dimensions were conducted using paired-samples t tests. When the assumptions for parametric testing were not met, the non-parametric Wilcoxon signed-rank test was applied. Associations between coping strategies were examined using Pearson correlation coefficients.

Between-group differences in Brief COPE strategies at the M2 assessment were analysed using analysis of variance (ANOVA). To enhance the robustness of the findings, Kruskal–Wallis tests were also performed. When statistically significant effects were identified, post hoc comparisons were conducted using Scheffé’s test to determine homogeneous subsets and to specify the groups in which differences occurred.

The selection of these analytical methods was based on the type of variables, sample size, and the need to ensure statistical robustness of the results. All statistical analyses were performed using IBM SPSS Statistics, version 28.

Results

As shown in Table 2, results obtained with the SOCRATES 8D scale indicated a significant increase in problem recognition scores following the intervention (t = 3.71, p < .001), as well as improvements in the ambivalence subscale (t = 2.57, p < .05) and taking steps (t = 5.19, p < .001). In contrast, assessment using the AWARE scale did not show significant differences between the pre- and post-intervention assessments (t = − 0.63, p > .05).

Table 2.

Descriptive statistics and mean difference test in the evaluation measures at timepoints M1 and M2

M 1 M 2 T-test value
Mean SD Mean SD
SOCRATES
Recognition 21.36 4.40 24.39 4.01 3.71***
Ambivalence 12.00 3.33 13.82 3.38 2.57*
Taking Steps 23.89 4.91 28.82 4.76 5.19***
AWARE
Aware Score 98.82 30.34 94.50 30.85 -0.63
Brief COPE Inventory
Active Coping 3.50 0.61 3.86 0.61 2.352*
Planning 2.66 0.61 2.96 1.11 1.256
Instrumental Support 2.64 0.68 2.48 0.59 -1.14
Emotional Support 3.45 0.50 3.77 0.69 1.924+
Self-Distraction 3.57 0.57 3.46 0.59 -0.827
Venting 3.11 0.58 3.04 0.72 -0.415
Behavioral Disengagement 3.38 0.75 3.32 0.76 -0.297
Positive Reframing 2.68 0.55 3.36 1.10 2.676*
Denial 3.54 0.76 3.59 0.67 0.294
Acceptance 2.86 0.52 3.41 1.01 2.663*
Religion 2.68 0.77 2.89 0.79 1.536
Substance Use 3.09 0.79 2.73 1.16 -1.404
Humor 2.75 0.91 2.57 0.79 -0.88
Self-Blame 3.00 0.91 2.80 0.72 -1.036
Global Questionnaire l
Understanding of Addiction 5.25 1.40
Risk Management 5.48 1.12
Usefulness and Application 5.55 1.30
Confidence-Motivation 5.63 1.40
Overall Evaluation 6.18 1.28
Total Evaluation 5.55 1.14

+p < .10; * p < .05; ** p < .01; *** p < .001

With regard to coping strategies assessed using the Brief COPE, significant improvements were observed in active coping (t = 2.35, p < .05), positive reframing (t = 2.67, p < .05) and acceptance (t = 2.66, p < .05). The emotional support subscale showed a marginal increase (t = 1.92, p < .10). No significant changes were detected in the remaining dimensions. Non-parametric Wilcoxon tests confirmed these results, as reported in Supplementary Material, Sect. 3. Overall, the findings reflect a shift towards more active and cognitive coping strategies, without relevant changes in avoidant strategies.

In the analysis of correlations among Brief COPE coping strategies, associations observed at baseline (M1) were scarce and of limited significance, with no clinically meaningful pattern (see Supplementary Material, Sect. 4). However, at the second assessment point (M2), following programme implementation, significant correlations emerged between several strategies and the substance use subscale (see Table 3), suggesting a differential effect of the programme on coping mechanisms.

Table 3.

Correlations between COPE constructs at time point M2

1 2 3 4 5 6 7 8 9 10 11 12 13 14
1. Active Coping --
2. Planning 0.664** --
3. Instrumental Support 0.227 0.312 --
4. Emotional Support 0.406* 0.546** 0.266 --
5. Self-Distraction 0.398* 0.307 0.426* 0.32 --
6. Venting 0.437* 0.372 0.552** 0.392* 0.329 --
7. Behavioural Disengagement -0.098 0.058 0.222 0.024 -0.035 0.351 --
8. Positive Reframing 0.563** 0.832** 0.225 0.382* 0.318 0.368 0.244 --
9. Denial -0.105 0.079 0.313 0.087 0.079 0.379* 0.835** 0.206 --
10. Acceptance 0.629** 0.870** 0.217 0.556** 0.304 0.336 0.22 0.819** 0.205 --
11. Religion 0.219 0.440* 0.076 0.192 0.25 0.269 0.339 0.408* 0.337 0.524** --
12. Substance Use -0.505** -0.740** 0.061 -0.162 -0.001 -0.121 0.122 -0.603** 0.092 -0.607** -0.287 --
13. Humor -0.036 0.214 0.263 0.134 0.105 0.207 0.484** 0.288 0.304 0.298 0.445* -0.12 --
14. Self-Blame -0.045 0.106 0.669** 0.054 0.156 0.387* 0.136 -0.013 0.363 -0.05 0.124 0.023 0.122 --

* Correlation is significant at the 0.05 level (2-tailed)

** Correlation is significant at the 0.01 level (2-tailed)

Specifically, substance use showed strong negative associations with planning (r = − .74, p < .001), acceptance (r = − .61, p < .001), and positive reframing (r = − .60, p < .001), indicating that participants who employed more structured and cognitive strategies reported lower substance use. In addition, active coping was positively correlated with planning (r = .66, p < .001) and emotional support (r = .41, p < .05), while positive reframing showed a robust association with acceptance (r = .82, p < .001). These findings support the hypothesis that adaptive strategies tend to be functionally integrated and may act as protective factors against relapse. Conversely, a significant association was observed between denial and behavioural disengagement (r = .84, p < .001), suggesting that in the absence of active coping, emotional and behavioural avoidance mechanisms tend to co-occur.

Regarding between-group differences, no significant discrepancies in coping strategies were observed at programme entry (M1). However, following the intervention (M2), statistically significant differences were identified across several Brief COPE subscales (see Table 4). Specifically, significant main effects of group were found for active coping (F(2, 25) = 10.97, p < .001), planning (F(2, 25) = 63.71, p < .001), positive reframing (F(2, 25) = 64.52, p < .001), emotional support (F(2, 25) = 5.39, p = .011), acceptance (F(2, 25) = 37.83, p < .001), and substance use (F(2, 25) = 30.18, p < .001). The non-parametric Kruskal–Wallis test yielded consistent results, further supporting the robustness of these findings (see Supplementary Material, Sect. 5).

Table 4.

ANOVA tests for group differences in COPE dimensions at M1 and M2. F statistic, p-value, and Scheffé post hoc test results

M1 F p-value M2 F p-value Scheffé post hoc test (when F test p < .05)
Active Coping 1.646 0.213 Active Coping 10.966 < 0.001 1 ≈ 2<3
Planning 0.242 0.787 Planning 63.709 < 0.001 1 ≈ 2<3
Instrumental Support 3.188 0.058 Instrumental Support 0.411 0.668 na
Emotional Support 3.593 0.043(1) Emotional Support 5.389 0.011 1 < 3; 2 ≈ 1, 2 ≈ 3
Self-Distraction 0.193 0.825 Self-Distraction 0.710 0.501 na
Venting 0.505 0.610 Venting 1.561 0.230 na
Behavioural Disengagement 0.711 0.501 Behavioural Disengagement 0.077 0.926 na
Positive Reframing 3.334 0.052 Positive Reframing 64.516 < 0.001 2 < 1<3
Denial 0.178 0.838 Denial 0.060 0.942 na
Acceptance 0.086 0.918 Acceptance 37.833 < 0.001 1 = 2<3
Religion 0.108 0.898 Religion 2.286 0.123 na
Substance Use 3.367 0.051 Substance Use 30.181 < 0.001 3 < 1≈2
Humor 0.071 0.932 Humor 1.056 0.363 na
Self-Blame 0.608 0.552 Self-Blame 0.089 0.915 na

(1) Although the F statistic showed a p-value < 0.05, the Scheffé post hoc test (calculated with an alpha level of 0.05) did not yield statistically significant results; the means of the three groups were clustered within the same subset

na: not applicable

In Scheffé tests, values indicate the relationship between groups (e.g., 1 ≈ 2 < 3 indicates that Group 3 has a significantly higher mean than Groups 1 and 2, which do not differ significantly from each other)

Post hoc analysis using Scheffé’s test revealed relevant nuances. Group 3 (Women’s Unit) obtained significantly higher scores than the other two groups in active coping, planning, and acceptance (p < .05). For positive reframing, Group 3 outperformed both other groups, although Group 1 also showed higher scores than Group 2. In the case of emotional support, Group 3 scored significantly higher than Group 1 but did not differ significantly from Group 2. With respect to substance use, scores were significantly lower in Group 3 (p < .001) compared with the other two groups, indicating a particularly favourable effect of the programme among female participants.

Finally, evaluation of the intervention using the ad hoc Global Questionnaire revealed high scores across all dimensions (means above 5 on a 1–7 scale), with particularly high ratings for items related to understanding addiction, identification of relapse warning signs, and planning for relapse prevention. These descriptive results reinforce the quantitative findings, providing additional evidence of clinical utility and participant acceptance of the programme.

Discussion

The findings are consistent with the usefulness of the Relapse Prevention Program in a prison context. Regarding the first objective, the SOCRATES 8D scale showed significant improvements across the three assessed dimensions—problem recognition, ambivalence, and taking steps—suggesting a strengthening of motivation for change. However, in the present sample, internal consistency for this scale was low, which reduces the precision of the estimated motivational change and warrants interpreting these results as preliminary. Accordingly, changes observed in motivational dimensions should be interpreted as indicative trends rather than definitive estimates of effect. Motivation is therefore considered a preliminary outcome requiring confirmation through more robust measures and multimethod triangulation. The increase in problem recognition is consistent with literature linking higher levels of motivation for change, particularly in the taking steps dimension, with better subsequent substance use outcomes [9]. In turn, the increase in ambivalence following the intervention aligns with findings from Motivational Interviewing, where ambivalence is conceptualised as an expected and clinically useful phenomenon rather than resistance, as it facilitates more elaborated reflection on addictive behaviour and change [2, 49, 53]. Moreover, recent synthesised evidence supports Motivational Interviewing as an evidence-based intervention for reducing substance use, albeit with heterogeneity across studies [24].

With respect to the taking steps dimension, the results indicate that participants began to adopt concrete strategies oriented towards abstinence, representing a clinically relevant advance in addiction treatment. Nevertheless, initiating change-oriented behaviours does not necessarily translate into sustained reductions in use without continuity of care and subsequent support, particularly among individuals with greater clinical severity. In this regard, recent evidence on continuing care highlights that maintaining follow-up interventions beyond the initial treatment phase is associated with better outcomes and greater stability of change [44]. It is therefore essential to consider additional mediating variables, especially emotional regulation and coping strategies, as critical components for consolidating change and preventing relapse.

Regarding scores on the AWARE scale, no significant differences were found between pre- and post-intervention assessments. Although initially unexpected, this result provides valuable information about the potential limitations in sensitivity to change of certain measures in highly structured environments such as prisons. One possible explanation is that a highly controlled context with limited exposure to substance-related cues constrains the activation of anticipatory and self-monitoring processes related to relapse risk. In addition, synthesised evidence indicates that individuals with substance use disorders show, on average, greater difficulties in emotional regulation than those without such disorders, a clinically relevant factor for vulnerability to substance use episodes under stress [62]. The stability observed on this scale may therefore reflect the need to incorporate more specific emotional training and early detection of internal warning signs, particularly in profiles with psychiatric comorbidity or severe substance use trajectories. At the same time, the psychometric validity of AWARE as a measure of early relapse warning signs has been documented, although its sensitivity to change may depend on context and the actual range of risk variation during the assessment period [33]. In addition, the prison context may influence responses obtained through self-report measures, as individuals’ subjective perceptions of risk and personal capacities can be shaped by institutional dynamics such as surveillance, routine environmental control, and behavioural adaptation to the regime. In offender samples, social desirability processes (including impression management and self-deception) have been shown to distort self-reports of clinically relevant and dynamic risk factors, which underscores the need for heightened methodological caution when interpreting self-report data in these settings [13, 30].

The literature on prison climate and quality of life indicates that these relational and organisational dimensions are associated with relevant attitudes and behaviours, making it plausible that they also affect how individuals respond to psychological measures [3, 15]. In parallel, recent work on measurement in prison populations emphasises the need to verify psychometric properties and measurement equivalence across subgroups, precisely because the context may introduce systematic response biases [4].

With respect to the third objective, Brief COPE results showed a shift towards more adaptive coping strategies, consistent with evidence indicating that cognitive–behavioural interventions for substance use disorders improve clinical outcomes and strengthen coping skills as a relevant mechanism of change [10, 41]. In the present study, the inverse association between the substance use subscale and strategies such as planning, positive reframing, and acceptance at post-intervention assessment (M2) suggests a pattern compatible with reduced vulnerability to relapse, in line with longitudinal studies showing higher levels of adaptive coping among individuals who maintain abstinence and greater use of maladaptive strategies among those who relapse [54, 55]. Taken together, these findings reinforce the importance of promoting a broad and functional coping repertoire as a therapeutic target, given that diversity and consistent use of coping skills have been associated with better post-treatment outcomes. Nevertheless, given the absence of a control group, the observed effects should be interpreted with caution and do not allow for direct causal attribution to the intervention.

Complementarily, the observed correlation between denial and behavioural disengagement suggests that when action-oriented coping strategies are not activated, avoidant patterns tend to consolidate. This profile is clinically relevant because avoidance and “disengagement” have been associated with poorer substance use trajectories and greater vulnerability to relapse in longitudinal studies; specifically, denial has been linked to a higher likelihood of relapse, and behavioural disengagement to a lower probability of short-term cessation, pointing to a profile of poorer clinical prognosis [61]. In parallel, literature on avoidance processes indicates that reducing experiential avoidance may be a relevant therapeutic goal, given its association with craving, a robust predictor of relapse [57]. Overall, these findings support the notion that the programme not only promotes adaptive strategies but also explicitly identifies and modulates avoidant responses that may interfere with maintenance of change.

The differences observed between groups at post-intervention assessment (M2) suggest clinically relevant patterns that may be linked to differential needs and trajectories. In particular, the women’s group showed more pronounced increases in adaptive strategies such as active coping, planning, positive reframing, emotional support, and acceptance, alongside a significant reduction in substance use. This pattern is consistent with synthesised evidence suggesting that gender-responsive programmes may achieve superior outcomes compared with “gender-neutral” approaches among women, particularly when higher-quality studies are considered and appropriate implementation conditions are ensured [28, 64]. In addition, recent reviews underscore the relevance of integrating gender-responsive principles that address needs related to victimisation, relationships, and trauma, as well as continuity of support, to maximise intervention impact [56].

By contrast, the lower use of adaptive strategies in the mental health unit suggests that individuals with concurrent disorders may require longer or more intensive interventions to consolidate emotional regulation and coping competencies. Evidence on integrated treatments for co-occurring disorders, together with reviews focusing on mental health services in prison settings, highlights the importance of coordinated approaches to mental health and substance use, as well as the need to strengthen continuity of care and transitional support to the community, particularly for profiles with greater clinical complexity [18, 31, 51, 59].

The high ratings obtained on the ad hoc Global Questionnaire suggest good acceptability of the RPP and reasonable alignment with participants’ perceived needs. In the addiction field, treatment satisfaction and the quality of the therapeutic relationship have been associated with greater engagement and better indicators of therapeutic progress, including in samples with justice system involvement [38, 68]. Moreover, meta-analytic evidence indicates that the therapeutic alliance maintains a positive association with outcomes beyond baseline characteristics and concurrent processes, making it a relevant component for sustaining change [23]. Given that retention and adherence are only moderately related to therapeutic success, this positive evaluation should be interpreted as an indicator of acceptability and engagement rather than as direct evidence of clinical effectiveness [14].

This study proposes a programmatic integration of the classic Relapse Prevention model (Marlatt & Gordon) with the COM-B/Behaviour Change Wheel (BCW) framework. The BCW provides an explicit logic for linking behavioural determinants (capability, opportunity, and motivation) with intervention functions and has been proposed as a useful approach for characterising and designing health-related behaviour change interventions [46]. In prison settings, recent qualitative studies have shown that the COM-B/BCW framework allows for the characterisation of substance use determinants and the derivation of intervention functions aligned with institutional constraints and dynamics, as well as the identification of relevant mechanisms, barriers, and facilitators for the implementation of brief psychosocial interventions [26, 27]. In the present study, this integration was translated into specific therapeutic contents and a programme organisation oriented towards plausible relapse mechanisms; however, components were not evaluated independently, precluding attribution of differential effects to each framework element. Accordingly, results should be interpreted as consistent with the hypothesis that an integrated formulation may facilitate programme coherence and implementation, rather than as evidence of mechanistic superiority.

The transferability of this proposal to other prison systems should be considered a reasonable objective, albeit contingent on service organisation, continuity of care, and the capacity to sustain the intervention with fidelity. Recent evidence confirms a high and complex burden of mental and physical morbidity in prison populations, reinforcing the need for integrated and realistic public health models [20, 34]. Furthermore, recent systematic reviews indicate that interventions with evidence of effectiveness exist for reducing critical harms (e.g., mortality) as well as justice-related outcomes (e.g., re-incarceration/recidivism) among people who use drugs with prison experience, both during incarceration and following release, although evidence gaps and programme heterogeneity persist [39]. Future research should therefore combine outcome evaluation with process evaluation, including fidelity, adaptations, and implementation conditions, to delineate which components are essential and in which contexts the proposed integration is most effective.

Practical implications and strengths of the study

The intervention implemented constitutes an applied proposal delivered in a real prison setting and targeted at individuals with dual diagnosis and high clinical vulnerability. A central strength lies in the programmatic integration of two complementary theoretical frameworks—Relapse Prevention and the COM-B/Behaviour Change Wheel model—used to structure programme contents, objectives, and intervention strategies. This integration allows intervention not only on addictive behaviour itself, but also on key determinants of change that are particularly relevant in prison contexts, such as readiness for change, individual capabilities, and contextual opportunities.

Unlike purely observational approaches, the present study evaluates a structured intervention using a pre–post design focused on clinically relevant variables, thereby enhancing its applied value and relevance for practice under real operational conditions. This orientation is consistent with systematic reviews highlighting the need for evidence-based interventions and continuity of care following release in order to optimise outcomes and reduce subsequent risks, within a field characterised by heterogeneity across programmes and methodological gaps [7, 16]. At the same time, these reviews recommend caution in interpreting estimates derived from small sample sizes and emphasise the need for replication in larger samples to strengthen robustness. This supports presenting the current findings as preliminary and transferable, rather than definitive.

In addition, the study incorporates a gender-sensitive perspective by exploring differences in the women’s unit. This approach is clinically relevant, as available evidence suggests that gender-responsive and transitional programmes, with continuity of care and integrated attention to mental health and substance use, are associated with better outcomes among women [19].

Limitations

A primary limitation of the study is the small sample size, which restricts the generalisability of the findings. This feature is consistent with a design oriented towards clinical implementation under restrictive operational conditions, but it requires cautious interpretation of results and prioritisation of future replications with greater statistical power and, where feasible, more rigorous comparative designs. In addition, some measures showed internal consistency below recommended thresholds. In particular, internal consistency for the SOCRATES-8D was low in the present sample, warranting caution when interpreting motivation-related findings. This issue is relevant given that the literature recommends prudence when interpreting effects derived from studies with small samples and high heterogeneity, especially when complex clinical outcomes are assessed [7].

Second, exclusive reliance on self-report measures may introduce information and social desirability biases, particularly for sensitive variables such as motivation, coping, or perceived risk. Triangulation with institutional records, behavioural indicators, and external measures would reduce this risk and strengthen result validity [1, 37]. Moreover, the absence of medium- or long-term follow-up prevents estimation of change stability; therefore, future studies should incorporate longitudinal assessments to evaluate maintenance of effects and clinical trajectories.

Third, structured diagnostic interviews were not used to standardise the assessment of comorbidity, nor were trauma histories systematically evaluated. This omission limits fine-grained tailoring of the intervention to clinical profiles and constrains the analysis of potential moderators of effect. Clinical guidelines for co-occurring disorders explicitly emphasise the need for integrated assessment and screening/diagnostic protocols in such cases (Substance Abuse and Mental Health Services Administration [SAMHSA], 2020). In addition, empirical evidence indicates high levels of trauma exposure and clinically relevant PTSD symptoms in prison populations, supporting the systematic inclusion of trauma assessment in intervention studies [67].

Finally, although the programme integrates Relapse Prevention and COM-B/BCW, the study did not independently evaluate which components were most active. Nor was a formal fidelity assessment implemented (e.g., standardised checklist or external observation), limiting attribution of observed outcomes to specific programme elements. Factorial or comparative designs, combined with process evaluation, would allow disaggregation of contributions and enhance the specificity of recommendations. Furthermore, implementation in a single centre limits institutional extrapolation and reinforces the need for multicentre replication.

Conclusions

The findings are consistent with the utility of integrating complementary theoretical frameworks to design relapse prevention interventions in prison settings. The combination of Relapse Prevention and the COM-B/BCW framework provides an operational architecture for identifying determinants of change and translating them into therapeutic objectives that are applicable under institutional conditions. Given the sample size and study design, these findings should be interpreted as preliminary evidence and require replication in larger samples with longitudinal follow-up, maintaining a conservative interpretation of effects [7].

From an applied perspective, the results suggest the value of structured and feasible programmes embedded within routine institutional practice, particularly when articulated with continuity of care following release and with strategies adapted to concurrent needs and gender sensitivity. Future evaluations should incorporate multimethod measurement and process analysis (fidelity, adaptations, and implementation conditions) to delineate which components are essential and in which contexts the proposed integration is most effective.

Supplementary Information

Below is the link to the electronic supplementary material.

Acknowledgements

We thank the Topas Penitentiary Centre (Salamanca, Spain) for facilitating the implementation of the study, as well as the professional intervention team and the participating inmates for their active involvement. We also acknowledge the collaboration of Cáritas Diocesana de Zamora (Spain) in the social reintegration processes, and the valuable methodological support provided by Senior Lecture Libia Santos Requejo.

Abbreviations

RPP

Relapse Prevention Program

COM-B

Capability, Opportunity, Motivation – Behaviour

BCW

Behaviour Change Wheel

SOCRATES-8D

Stages of Change Readiness and Treatment Eagerness Scale, substance use disorder version

AWARE

Advance Warning of Relapse Scale

Brief COPE

Brief Coping Orientation to Problems Experienced

UTE

Therapeutic and Educational Unit

CEISH

Research Ethics Committee

IBM SPSS

International Business Machines – Statistical Package for the Social Sciences

DSM-5

Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition

ICD-10

International Classification of Diseases, Tenth Revision

PTSD

Post-Traumatic Stress Disorder

M1 / M2

Measurement 1 (pre-intervention) / Measurement 2 (post-intervention)

UNODC

United Nations Office on Drugs and Crime

SAMHSA

Substance Abuse and Mental Health Services Administration

Author contributions

Abdón Martín-Coca conducted the study design, methodological planning, intervention delivery, data collection, statistical analysis, and full drafting of the manuscript. José Antonio Martín Herrero supervised the process and approved the final version of the manuscript.

Funding

This study did not receive specific funding from public, commercial, or non-profit agencies.

Data availability

The dataset generated during this study will be made available via the Figshare repository; [https://figshare.com/s/6921cd7bafe4039dfc6a] .The access link will be provided to the journal during the editorial process for review purposes, ensuring full transparency. For additional inquiries, the corresponding author may be contacted.

Declarations

Ethics approval and consent to participate

The study was approved by the Ethics Committee of the University of Salamanca (Comité de Ética de la Investigación con Seres Humanos, CEISH), approval code 1155, by resolution dated March 7, 2024. Authorisation to conduct the intervention was granted by the Ministry of the Interior and the General Secretariat of Penitentiary Institutions on March 21, 2024.

Consent for publication

All participants provided written informed consent for the publication of anonymised data derived from the study.

AI use statement

Artificial intelligence was not used for data generation or statistical analysis in this study. However, automated support was employed exclusively to facilitate the translation of the manuscript from Spanish into English, under the direct supervision of the authors. The interpretation, writing, and final revision of the text were carried out manually and responsibly by the research team.

Competing interests

The authors declare no competing interests.

Footnotes

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

References

  • 1.Althubaiti A. Information bias in health research: Definition, pitfalls, and adjustment methods. J Multidisciplinary Healthc. 2016;9:211–7. 10.2147/JMDH.S104807. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Apodaca TR, Longabaugh R. Mechanisms of change in motivational interviewing: A review and preliminary evaluation of the evidence. Addiction. 2009;104(5):705–15. 10.1111/j.1360-0443.2009.02527.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Auty KM, Liebling A. Exploring the relationship between prison social climate and recidivism. Justice Q. 2020;37(2):358–81. 10.1080/07418825.2018.1538421. [Google Scholar]
  • 4.Baker T, Ray JV, Nobles MR. Measuring people in prison’s perceptions of correctional officer procedural justice. J Criminal Justice. 2025;99:102459. 10.1016/j.jcrimjus.2025.102459. [Google Scholar]
  • 5.Bandura A. Self-efficacy: the exercise of control. W.H. Freeman; 1997.
  • 6.Baranyi G, Fazel S, Langerfeldt SD, Mundt AP. The prevalence of comorbid serious mental illnesses and substance use disorders in prison populations: A systematic review and meta-analysis. Lancet Public Health. 2022;7(6):e557–68. 10.1016/S2468-2667(22)00093-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Beaudry G, Yu R, Perry AE, Fazel S. Effectiveness of psychological interventions in prison to reduce recidivism: A systematic review and meta-analysis of randomised controlled trials. Lancet Psychiatry. 2021;8(9):759–73. 10.1016/S2215-0366(21)00170-X. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Boateng GO, Neilands TB, Frongillo EA, Melgar-Quiñonez HR, Young SL. Best practices for developing and validating scales for health, social, and behavioral research: A primer. Front Public Health. 2018;6:149. 10.3389/fpubh.2018.00149. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Burrow-Sánchez JJ, Corrales C, Totsky J. Predictive validity of the SOCRATES in a clinical sample of Latina/o adolescents. Psychol Addict Behav. 2019;33(2):171–7. 10.1037/adb0000432. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Carroll KM, Onken LS. Behavioral therapies for drug abuse. Am J Psychiatry. 2005;162(8):1452–60. 10.1176/appi.ajp.162.8.1452. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Carver CS. You want to measure coping but your protocol’s too long: consider the brief COPE. Int J Behav Med. 1997;4(1):92–100. 10.1207/s15327558ijbm0401_6. [DOI] [PubMed] [Google Scholar]
  • 12.Chandler RK, Fletcher BW, Volkow ND. Treating drug abuse and addiction in the criminal justice system: improving public health and safety. JAMA. 2009;301(2):183–90. 10.1001/jama.2008.976. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Cobo B, Castillo E, López-Torrecillas F, Rueda MdelM. Indirect questioning methods for sensitive survey questions: modelling criminal behaviours among a prison population. PLoS ONE. 2021;16(1):e0245550. 10.1371/journal.pone.0245550. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Dacosta-Sánchez D, González-Ponce BM, Fernández-Calderón F, Sánchez-García M, Lozano OM. Retention in treatment and therapeutic adherence: How are these associated with therapeutic success? An analysis using real-world data. Internat J Method Psychiat Res. 2022;31(4), e1929. 10.1002/mpr.1929. [DOI] [PMC free article] [PubMed]
  • 15.Day A, Casey S, Vess J, Huisy G. Assessing the therapeutic climate of prisons. Criminal Justice Behav. 2012;39(2):156–68. 10.1177/0093854811430476. [Google Scholar]
  • 16.de Andrade D, Ritchie J, Rowlands M, Mann E, Hides L. Substance use and recidivism outcomes for prison-based drug and alcohol interventions. Epidemiol Rev. 2018;40(1):121–33. 10.1093/epirev/mxy004. [DOI] [PubMed] [Google Scholar]
  • 17.Doerfler LA, Melle D, McLaughlin T, Fisher WH. Do stages of change readiness and treatment eagerness scale (SOCRATES) scores predict readmission to an inpatient substance abuse treatment program for adolescents? J Child Adolesc Subst Abuse. 2016;25(6):516–21. 10.1080/1067828X.2015.1111822. [Google Scholar]
  • 18.Drake RE, O’Neal EL, Wallach MA. A systematic review of psychosocial research on psychosocial interventions for people with co-occurring severe mental and substance use disorders. J Subst Abuse Treat. 2008;34(1):123–38. 10.1016/j.jsat.2007.01.011. [DOI] [PubMed] [Google Scholar]
  • 19.Edwards L, Kendall Jamieson S, Bowman J, Chang S, Newton J, Sullivan E. A systematic review of post-release programs for women exiting prison with substance-use disorders: assessing current programs and weighing the evidence. Health Justice. 2022;10(1). 10.1186/s40352-021-00162-6. [DOI] [PMC free article] [PubMed]
  • 20.Favril L, Rich JD, Hard J, Fazel S. Mental and physical health morbidity among people in prisons: an umbrella review. Lancet Public Health. 2024;9(4):e250–60. 10.1016/S2468-2667(24)00023-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Fazel S, Hayes AJ, Bartellas K, Clerici M, Trestman R. Mental health of prisoners: Prevalence, adverse outcomes, and interventions. Lancet Psychiatry. 2016;3(9):871–81. 10.1016/S2215-0366(16)30142-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Fernández-Martín FD, Flores-Carmona L, Arco-Tirado JL. Coping strategies among undergraduates: Spanish adaptation and validation of the brief-COPE inventory. Psychol Res Behav Manage. 2022;15:991–1003. 10.2147/PRBM.S356288. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Flückiger C, Del Re AC, Wlodasch D, Horvath AO, Solomonov N, Wampold BE. Assessing the alliance–outcome association adjusted for patient characteristics and treatment processes: A meta-analytic summary of direct comparisons. J Couns Psychol. 2020;67(6):706–11. 10.1037/cou0000424. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Frost H, Campbell P, Maxwell M, O’Carroll RE, Dombrowski SU, Williams B, Cheyne H, Coles E, Pollock A. Effectiveness of motivational interviewing on adult behaviour change in health and social care settings: A systematic review of reviews. PLoS ONE. 2018;13(10):e0204890. 10.1371/journal.pone.0204890. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Garland EL, Manusov EG, Froeliger B, Kelly A, Williams JM, Howard MO. Mindfulness-oriented recovery enhancement for chronic pain and prescription opioid misuse: results from an early-stage randomized controlled trial. J Consult Clin Psychol. 2014;82(3):448–59. 10.1037/a0035798. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Ghosh A, Pillai RR, Vij J, Nain R, Shetty D, Maulik PK, Basu D. Substance use in the correctional settings: A qualitative exploration of individual and contextual characteristics and intervention strategies using the behavior change wheel framework. J Subst Use Addict Treat. 2024;158:209257. 10.1016/j.josat.2023.209257. [DOI] [PubMed] [Google Scholar]
  • 27.Ghosh A, Pillai RR, Vij J, Maulik PK, George BB, Basu D. Understanding the active ingredients, barriers, and facilitators to implement brief psychological interventions for substance misuse in Indian prisons: A qualitative study. Indian J Psychiatry. 2025;67(2):236–44. 10.4103/indianjpsychiatry.indianjpsychiatry_634_24. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Gobeil R, Blanchette K, Stewart L. A meta-analytic review of correctional interventions for women offenders: Gender-neutral versus gender-informed approaches. Criminal Justice Behav. 2016;43(3):301–22. 10.1177/0093854815621100. [Google Scholar]
  • 29.Goldstein RZ, Volkow ND. Dysfunction of the prefrontal cortex in addiction: neuroimaging findings and clinical implications. Nat Rev Neurosci. 2011;12(11):652–69. 10.1038/nrn3119. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Hildebrand M, Wibbelink CJM, Verschuere B. Do impression management and self-deception distort self-report measures with content of dynamic risk factors in offender samples? A meta-analytic review. Int J Law Psychiatry. 2018;58:157–70. 10.1016/j.ijlp.2018.02.013. [DOI] [PubMed] [Google Scholar]
  • 31.Jordan AE, Kashino W, Suhartono S, Campello G, Busse A. A systematic review and narrative synthesis of interventions to address substance use disorders and other mental health disorders in prison settings with a focus on Low- and Middle-Income countries. Criminal Justice Behav. 2023;50(6):787–805. 10.1177/00938548231166155. [Google Scholar]
  • 32.Kadi M, Bourion-Bédès S, Bisch M, Baumann C. A structural validation of the brief COPE scale among outpatients with alcohol and opioid use disorders. Int J Environ Res Public Health. 2023;20(3):2695. 10.3390/ijerph20032695. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Kelly JF, Hoeppner BB, Urbanoski KA, Slaymaker V. Predicting relapse among young adults: psychometric validation of the advanced warning of relapse (AWARE) scale. Addict Behav. 2011;36(10):987–93. 10.1016/j.addbeh.2011.05.013. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Kinner SA, Young JT. Understanding and improving the health of people who experience incarceration: an overview and synthesis. Epidemiol Rev. 2018;40(1):4–11. 10.1093/epirev/mxx018. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Komalasari R, Wilson S, Haw S. A systematic review of qualitative evidence on barriers to and facilitators of the implementation of opioid agonist treatment programmes in prisons. Int J Drug Policy. 2021;87:102978. 10.1016/j.drugpo.2020.102978. [DOI] [PubMed] [Google Scholar]
  • 36.Koob GF, Volkow ND. Neurobiology of addiction: A neurocircuitry analysis. Lancet Psychiatry. 2016;3(8):760–73. 10.1016/S2215-0366(16)00104-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Krumpal I. Determinants of social desirability bias in sensitive surveys: a literature review. Qual Quant. 2013;47:2025–47. 10.1007/s11135-011-9640-9. [Google Scholar]
  • 38.Kuusisto K, Lintonen T. Factors predicting satisfaction in outpatient substance abuse treatment: A prospective follow-up study. Subst Abuse Treat Prev Policy. 2020;15(1):35. 10.1186/s13011-020-00275-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Macdonald C, Macpherson G, Leppan O, Tran LT, Cunningham EB, Hajarizadeh B, Grebely J, Farrell M, Altice FL, Degenhardt L. Interventions to reduce harms related to drug use among people who experience incarceration: systematic review and meta-analysis. Lancet Public Health. 2024;9(9):e684–99. 10.1016/S2468-2667(24)00160-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Magill M, Martino S, Wampold BE. The process of skills training: A content analysis of evidence-based addiction therapies. J Subst Abuse Treatment. 2020;116. 10.1016/j.jsat.2020.108063. [DOI] [PMC free article] [PubMed]
  • 41.Magill M, Kiluk BD, Ray LA. Efficacy of cognitive behavioral therapy for alcohol and other drug use disorders: is a one-size-fits-all approach appropriate? Subst Abuse Rehabilitation. 2023;14:1–11. 10.2147/SAR.S362864. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Marlatt GA, Gordon JR. Relapse prevention: maintenance strategies in the treatment of addictive behaviors. Guilford Press; 1985.
  • 43.McKay JR. Making the hard work of recovery more attractive for those with substance use disorders. Addiction. 2017;112(5):751–7. 10.1111/add.13502. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.McKay JR. Impact of continuing care on recovery from substance use disorder. Alcohol Research: Curr Reviews. 2021;41(1):01. 10.35946/arcr.v41.1.01. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Melemis SM. Relapse prevention and the five rules of recovery. Yale J Biology Med. 2015;88(3):325–32. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4553654. [PMC free article] [PubMed] [Google Scholar]
  • 46.Michie S, Van Stralen MM, West R. The behaviour change wheel: A new method for characterising and designing behaviour change interventions. Implement Sci. 2011;6(1):42. 10.1186/1748-5908-6-42. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47.Michie S, Atkins L, West R. The behaviour change wheel: A guide to designing interventions. Silverback Publishing; 2014.
  • 48.Miller WR, Harris RJ. A simple scale of gorski’s warning signs for relapse. J Stud Alcohol. 2000;61(5):759–65. 10.15288/jsa.2000.61.759. [DOI] [PubMed] [Google Scholar]
  • 49.Miller WR, Rollnick S. Motivational interviewing: helping people change. Guilford Press; 2013.
  • 50.Miller WR, Tonigan JS. Assessing drinkers’ motivation for change: the stages of change readiness and treatment eagerness scale (SOCRATES). Psychol Addict Behav. 1996;10(2):81–9. 10.1037/0893-164X.10.2.81. [Google Scholar]
  • 51.Perry AE, Martyn-St James M, Burns L, Hewitt C, Glanville JM, Aboaja A, Thakkar P, Santoso KM, Wright K, Wilson P. Interventions for drug-using offenders with co-occurring mental health problems. Cochrane Database Syst Rev. 2019;10. 10.1002/14651858.CD010901.pub3. [DOI] [PMC free article] [PubMed]
  • 52.Power J, Smith H, Brown SL. The brief COPE: A factorial structure for incarcerated adults. Criminal Justice Stud. 2021;34(2):215–34. 10.1080/1478601X.2020.1827589. [Google Scholar]
  • 53.Prochaska JO, DiClemente CC. Transtheoretical therapy: toward a more integrative model of change. Psychotherapy: Theory Res Pract. 1982;19(3):276–88. 10.1037/h0088437. [Google Scholar]
  • 54.Roos CR, Witkiewitz K. Adding tools to the toolbox: the role of coping repertoire in alcohol treatment. J Consult Clin Psychol. 2016;84(7):599–611. 10.1037/ccp0000102. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 55.Roos CR, Maisto SA, Witkiewitz K. Coping mediates the effects of cognitive-behavioral therapy for alcohol use disorder among out-patient clients in project MATCH when dependence severity is high. Addiction. 2017;112(9):1547–57. 10.1111/add.13841. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 56.Salisbury EJ, Crawford A. Gender-responsive treatment to improve outcomes for women and girls in correctional settings: Foundations, limitations and innovations. Health Justice. 2025;13:11. 10.1186/s40352-025-00316-w. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 57.Shorey RC, Gawrysiak MJ, Elmquist J, Brem M, Anderson S, Stuart GL. Experiential avoidance, distress tolerance, and substance use cravings among adults in residential treatment for substance use disorders. J Addict Dis. 2017;36(3):151–7. 10.1080/10550887.2017.1302661. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 58.Sijtsma K. On the Use, the Misuse, and the very limited usefulness of cronbach’s alpha. Psychometrika. 2009;74(1):107–20. 10.1007/s11336-008-9101-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 59.Simpson AIF, Gerritsen C, Maheandiran M, Adamo V, Vogel T, Fulham L, Kitt T, Forrester A, Jones RM. A systematic review of reviews of correctional mental health services using the STAIR framework. Front Psychiatry. 2022;12:747202. 10.3389/fpsyt.2021.747202. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 60.Sinha R. Chronic stress, drug use, and vulnerability to addiction. Ann N Y Acad Sci. 2008;1141(1):105–30. 10.1196/annals.1441.030. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 61.Sosnowski DW, Feder KA, Astemborski J, Genberg BL, Johnson SB, Sun J, Maher BS, Musci RJ, Mehta SH, Kirk GD. Coping strategy as a predictor of illicit drug use among persons who inject drugs. Psychol Addict Behav. 2025. 10.1037/adb0001114. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 62.Stellern J, Xiao KB, Grennell E, Sanches M, Gowin JL, Sloan ME. Emotion regulation in substance use disorders: A systematic review and meta-analysis. Addiction. 2023;118(1):30–47. 10.1111/add.16001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 63.Substance Abuse and Mental Health Services Administration. Substance use disorder treatment for people with co-occurring disorders (Treatment Improvement Protocol [TIP] Series No. 42). 2020. https://www.ncbi.nlm.nih.gov/books/NBK571020/. [PubMed]
  • 64.Summers R, Pemberton S, Long J. Examining the effectiveness of interventions for criminal justice-involved women: A meta-analytic review. Criminal Justice Behav. 2025;52(5):690–715. 10.1177/00938548241304753. [Google Scholar]
  • 65.United Nations Office on Drugs and Crime. World drug report 2023. United Nations publication. 2023. https://www.unodc.org/unodc/en/data-and-analysis/world-drug-report-2023.html.
  • 66.Witkiewitz K, Marlatt GA. Relapse prevention for alcohol and drug problems: that was zen, this is Tao. Am Psychol. 2004;59(4):224–35. 10.1037/0003-066X.59.4.224. [DOI] [PubMed] [Google Scholar]
  • 67.Wolff N, Huening J, Shi J, Frueh BC. Trauma exposure and posttraumatic stress disorder among incarcerated men. J Urb Health. 2014;91(4):707–19. 10.1007/s11524-014-9871-x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 68.Yang Y, Gray J, Joe GW, Flynn PM, Knight K. Treatment retention, satisfaction, and therapeutic progress for justice-involved individuals referred to community-based medication-assisted treatment. Subst Use Misuse. 2019;54(9):1461–74. 10.1080/10826084.2019.1586949. [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Data Availability Statement

The dataset generated during this study will be made available via the Figshare repository; [https://figshare.com/s/6921cd7bafe4039dfc6a] .The access link will be provided to the journal during the editorial process for review purposes, ensuring full transparency. For additional inquiries, the corresponding author may be contacted.


Articles from Substance Abuse Treatment, Prevention, and Policy are provided here courtesy of BMC

RESOURCES